Sweden’s Cytely raises €3 million as labs report 75% faster analysis using its smart microscopy platform

Cytely, a Lund-based DeepTech start-up, has actually protected EUR3 million in a brand-new financing round to power the development of Cytely’s wise microscopy system, which changes common lab microscopic lens right into real-time information engines, considerably minimizing the moment researchers invest in hands-on evaluation.

The round was led by Ugly Duckling Ventures, with ongoing assistance from existing financier Icebreaker.vc. Cytely belongs to the profile at SmiLe Endeavor Center and has actually staff member based in Lund, San Diego, and Singapore.

“ Researchers have actually been constricted by process constructed for pictures, not information. Cytely changes any type of microscopic lense right into a real-time dimension tool, shutting the loophole from purchase to choice on an experiment-day timescale as opposed to a give cycle,” stated Philip Nordenfelt, Cytely Founder & CHIEF EXECUTIVE OFFICER. “ Our objective is to make every experiment analysis-ready from development, so explorations pile and scientific research substances.“

The financing introduced for Cytely fits within a more comprehensive European DeepTech and HealthTech pattern seen throughout 2025.

In February 2025, QT Sense (Netherlands) protected EUR6 million to create its quantum-sensing innovation for single-cell diagnostics, while Pixel Photonics (Germany) got EUR1 million in give financing to breakthrough multi-mode photon detectors for microscopy and diagnostics.

With each other, these increases show a common concentrate on automation, accuracy imaging, and data-centric study frameworks. Within this context, Cytely’s smart-microscopy technique– allowing real-time, analysis-ready information from common tools– settings it as component of an expanding European motion in the direction of obtainable, scalable clinical development.

“ Their vision is genuinely transformative. We’re enjoyed lead this round and sustain the goal to make wise, data‑centric microscopy obtainable to every laboratory,” stated Louise Lachmann, Companion at Ugly Duckling Ventures.

Established In 2023, Cytely constructs data-centric devices for organic exploration. Its core system permits laboratories to record, procedure, and evaluate complicated mobile information instantly. This makes the typically slow-moving and hands-on procedure of microscopy evaluation not just much faster however likewise statistically durable– opening brand-new opportunities for laboratories that might not have had accessibility to premium framework.

The business was co-founded by Philip Nordenfelt, that likewise functions as chief executive officer. With a history in immunology and mechanobiology, Nordenfelt brings both clinical and technological reliability to the table. His goal is to change the present microscopy traffic jam right into a feedback-rich operations that speeds up theory screening and exploration.

The system has actually currently been taken on by significant study organizations, consisting of Lund College, and is being made use of in biomedical study areas such as virology, oncology, and metabolic conditions.

“ Cytely’s software program is a democratising pressure in scientific research. It decouples world‑class exploration from world‑class financing, equipping any type of scientist with a microscopic lense to take on the largest difficulties in human health and wellness. All microscopy will certainly end up being ‘wise microscopy’; Cytely is transforming the ‘wild west’ of opportunity right into an effective, obtainable system that will certainly speed up exploration for scientists all over,” stated Dr Vinay Swaminathan, Head of the Research Laboratory of Cell & Molecular Mechanobiology at Lund College.

Typically, microscopy has actually focused on fixed pictures, leaving scientists to by hand analyze specific cells– a procedure that can take weeks and commonly falls short to create information with analytical self-confidence.

Cytely seeks to alter that standard by making information, not photos, the key result. Its system automates photo purchase, measures whole examples, and supplies outcomes that are standardised, reproducible, and analysis-ready in actual time. The software program is hardware-agnostic, made to deal with the majority of contemporary microscopic lens, getting rid of the demand for expensive, specialized imaging gears.

“ Ultimately, we seem like this job is really functioning … We’re gathering large‑scale information and unraveling devices of viral latency, something that simply had not been feasible prior to,” stated Prof. Alex Evilevitch

A situation from Lund College exhibits the system’s effect: scientists researching herpesvirus latency were formerly not able to refine greater than 0.1% of their example information as a result of hands-on restrictions. Making use of Cytely, they apparently refined almost 100% of examples and determined a formerly unobservable cell-line defense mechanism. The adjustment allowed them to upgrade their procedure and attain even more development in one month than in the previous 5 years.

Past academic community, Cytely is supplying solid returns in industrial setups. A cancer cells study laboratory making use of the system decreased hands-on evaluation time by 75%, conserving around EUR300k yearly– efficiently increasing its labor force.

A nanowire BioTech business raised its R&D throughput by 40%, approximating an added $1 million in yearly worth. An additional laboratory changed a EUR400k high-throughput imaging arrangement totally with Cytely’s pipe on existing microscopic lens.

The freshly protected financing will certainly sustain the advancement of smart purchase devices suitable with all microscopic lense brand names, and develop one-click process for scientists despite their information evaluation abilities.

These improvements intend to transform the system right into a totally incorporated exploration network, where confirmed methods and datasets can be shared, repeated, and repeated upon– eventually laying the structure for anticipating evaluation and partly self-governing study.

The blog post Sweden’s Cytely raises €3 million as labs report 75% faster analysis using its smart microscopy platform showed up initially on EU-Startups.